Abraxis BioScience Financial Statements
Abraxis BioScience Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Abraxis BioScience Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 333.7 | 765.5 | 518.8 |
| Gross Profit ($ mil.) | 299.2 | 458.0 | 292.9 |
| Operating Income ($ mil.) | (58.1) | 0.9 | 130.3 |
| Total Net Income ($ mil.) | (41.6) | (46.9) | 86.4 |
| Diluted EPS (Net Income) | (1.04) | (0.30) | 1.17 |
Abraxis BioScience Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 82.1 | 90.8 | 241.0 |
| Gross Profit ($ mil.) | 73.5 | 82.5 | 144.4 |
| Operating Income ($ mil.) | (2.2) | (6.6) | (7.3) |
| Total Net Income ($ mil.) | 4.3 | (5.2) | (8.4) |
| Diluted EPS (Net Income) | 0.11 | (1.04) | (0.05) |
Abraxis BioScience Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 7.87 | 3.69 | 1.58 |
| Price/Earnings Ratio | -- | 15.88 | 15.68 |
| Price/Book Ratio | 2.19 | 2.70 | 1.50 |
| Price/Cash Flow Ratio | -- | 11.61 | 9.70 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Abraxis BioScience Financial Ratios
Abraxis BioScience Competitive Intelligence
| Acusphere | Bristol-Myers Squibb | Sanofi-Aventis | |
|---|---|---|---|
| Annual Sales ($ mil.) | 2.7 | 19,348.0 | 43,019.0 |
| Employees | -- | 42,000 | 99,495 |
| Market Cap ($ mil.) | 25.2 | 38,848.3 | -- |
Competitive Landscape
